Stephens reaffirmed their overweight rating on shares of UnitedHealth Group (NYSE:UNH – Free Report) in a research note published on Thursday, Benzinga reports. They currently have a $605.00 target price on the healthcare conglomerate’s stock.
Several other analysts also recently commented on the stock. Morgan Stanley dropped their price objective on shares of UnitedHealth Group from $587.00 to $579.00 and set an overweight rating on the stock in a report on Monday, October 23rd. Oppenheimer reaffirmed an outperform rating and issued a $610.00 price objective on shares of UnitedHealth Group in a report on Wednesday, January 17th. Truist Financial reaffirmed a buy rating and issued a $610.00 price objective on shares of UnitedHealth Group in a report on Thursday, November 30th. Jefferies Financial Group dropped their price objective on shares of UnitedHealth Group from $565.00 to $503.00 and set a hold rating on the stock in a report on Monday, November 20th. Finally, Cantor Fitzgerald reissued an overweight rating and set a $591.00 price target on shares of UnitedHealth Group in a report on Friday, January 19th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of Moderate Buy and a consensus target price of $575.79.
UnitedHealth Group Trading Down 0.4 %
UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its quarterly earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.98 by $0.18. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The business had revenue of $94.43 billion for the quarter, compared to analyst estimates of $92.13 billion. During the same quarter in the prior year, the business posted $5.34 EPS. UnitedHealth Group’s revenue for the quarter was up 14.1% compared to the same quarter last year. As a group, sell-side analysts forecast that UnitedHealth Group will post 27.84 EPS for the current fiscal year.
In other news, Director Stephen J. Hemsley sold 66,081 shares of the stock in a transaction dated Tuesday, December 5th. The shares were sold at an average price of $550.39, for a total value of $36,370,321.59. Following the completion of the sale, the director now directly owns 635,528 shares in the company, valued at $349,788,255.92. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.35% of the company’s stock.
Institutional Investors Weigh In On UnitedHealth Group
Several hedge funds and other institutional investors have recently bought and sold shares of the company. Kraft Davis & Associates LLC increased its position in UnitedHealth Group by 3.4% during the third quarter. Kraft Davis & Associates LLC now owns 577 shares of the healthcare conglomerate’s stock worth $294,000 after purchasing an additional 19 shares during the last quarter. Iron Horse Wealth Management LLC boosted its stake in UnitedHealth Group by 1.6% during the third quarter. Iron Horse Wealth Management LLC now owns 1,217 shares of the healthcare conglomerate’s stock worth $614,000 after buying an additional 19 shares during the period. Secure Asset Management LLC boosted its stake in UnitedHealth Group by 0.8% during the third quarter. Secure Asset Management LLC now owns 2,456 shares of the healthcare conglomerate’s stock worth $1,238,000 after buying an additional 19 shares during the period. Bensler LLC boosted its stake in UnitedHealth Group by 0.3% during the third quarter. Bensler LLC now owns 7,293 shares of the healthcare conglomerate’s stock worth $3,677,000 after buying an additional 19 shares during the period. Finally, Texas Capital Bancshares Inc TX boosted its stake in UnitedHealth Group by 1.1% during the third quarter. Texas Capital Bancshares Inc TX now owns 1,695 shares of the healthcare conglomerate’s stock worth $855,000 after buying an additional 19 shares during the period. 85.69% of the stock is currently owned by institutional investors and hedge funds.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
- Five stocks we like better than UnitedHealth Group
- How to Use Stock Screeners to Find Stocks
- MarketBeat Week in Review – 2/5 – 2/9
- Investing in Commodities: What Are They? How to Invest in Them
- Cloudflare results spark analysts reset: 25% upside ahead
- What is an Earnings Surprise?
- Beyond Nvidia: The hidden stars with 200% earnings growth
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.